Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722813 · ClinicalTrials.gov registry record
Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 31
- Enrollment target
NCT00722813: Completed study, sponsored by University of Michigan.
NCT00722813 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00722813 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This is a research study to determine patient preferences between two different diagnostic tests; a CT angiogram (CTA) and a catheter angiogram, both of which are used at the University to screen for and detect heart disease.
Primary Outcome
Utility of CT and catheter angiography was compared within patients who had both tests performed.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2006-10 |
| Est. Completion | 2012-11 |
What the finished NCT00722813 record still lists
NCT00722813 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT00722813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00722813 about?
NCT00722813 is a clinical study titled "Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath". This is a research study to determine patient preferences between two different diagnostic tests; a CT angiogram (CTA) and a catheter angiogram, both of which are used at the University to screen for and detect heart disease.
What is the current status of trial NCT00722813?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2006-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00722813?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT00722813?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia